Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Total Liabilities (2016 - 2025)

PAVmed has reported Total Liabilities over the past 6 years, most recently at $16.5 million for Q4 2025.

  • For Q4 2025, Total Liabilities fell 56.19% year-over-year to $16.5 million; the TTM value through Dec 2025 reached $16.5 million, down 56.19%, while the annual FY2025 figure was $16.5 million, 56.19% down from the prior year.
  • Total Liabilities for Q4 2025 was $16.5 million at PAVmed, up from $12.3 million in the prior quarter.
  • Over five years, Total Liabilities peaked at $58.1 million in Q2 2024 and troughed at $3.3 million in Q1 2021.
  • A 5-year average of $30.9 million and a median of $28.6 million in 2022 define the central range for Total Liabilities.
  • Biggest five-year swings in Total Liabilities: surged 670.02% in 2022 and later crashed 79.44% in 2025.
  • Year by year, Total Liabilities stood at $7.6 million in 2021, then soared by 469.54% to $43.0 million in 2022, then soared by 32.73% to $57.1 million in 2023, then crashed by 34.03% to $37.7 million in 2024, then crashed by 56.19% to $16.5 million in 2025.
  • Business Quant data shows Total Liabilities for PAVM at $16.5 million in Q4 2025, $12.3 million in Q3 2025, and $12.5 million in Q2 2025.